Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 28. November 2025
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7721  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 154405  
   
Brief Report: Lung Cancer Diagnoses among Lung Cancer Screening Program Participants With Family History of Lung Cancer.
Clin Lung Cancer
Katcher JG, Shusted CC, Bhatt P, Ruane BM, Markle J, Kane GC, Wen KY, Juon HS, Barta JA.
PMID: 41308231 [PubMed - as supplied by publisher]


Predictors of Thirty-Day Morbidity and Unplanned Readmission after Induction Therapy Followed by Lung Resection for Non-Small Cell Lung Cancer: European Society of Thoracic Surgeons Database Analysis.
Eur J Cardiothorac Surg
Prisciandaro E, Bertolaccini L, Passani S, Szanto Z.
PMID: 41308163 [PubMed - as supplied by publisher]


Changing Epidemiology of Lung Cancer in Finland: A Registry-Based Study by Histology and Region.
Cancer Control
Puuniemi L, Mäkinen J, Koivunen J, Kaarteenaho R.
PMID: 41308077 [PubMed - indexed for MEDLINE]


Efficacy of Almonertinib Versus Osimertinib as the First-Line Treatment for Non-Small Cell Lung Cancer With EGFR L858R Mutation and Prognostic Analysis: A Retrospective Comparative Cohort Study.
Cancer Med
Yao X, Li R, Dong X, Li Y, Li Y.
PMID: 41308037 [PubMed - indexed for MEDLINE]


Monotherapy With Immune Checkpoint Inhibitors in Patients With Recurrent and/or Metastatic Sinonasal Squamous Cell Carcinoma.
Cancer Med
Lein A, Fuereder T, Stoeth M, Scherzad A, Hackenberg S, Schnöll J, Kadletz-Wanke L, Heiduschka G, Jaiswal A, Bhalla R, Kenner L, Brkic FF.
PMID: 41308007 [PubMed - indexed for MEDLINE]


Single-cell transcriptomic analysis reveals cellular and molecular changes in EGFR-positive lung adenocarcinoma before and after Furmonertinib treatment.
Genes Genomics
Chen J, Cai M, Meng L, Hong Z, Hu W.
PMID: 41307822 [PubMed - as supplied by publisher]


The changes of CD47 and PD-L1 (SP142) before and after neoadjuvant therapy help predict prognosis of patients with stage IIIA-N2 non-small cell lung cancer.
Int J Clin Oncol
Jiang Q, Lv Y, Liu Y, Gu L, Wang H, Yang Y.
PMID: 41307632 [PubMed - as supplied by publisher]


Exploring the association between air pollutants and non-small cell lung cancer using network toxicology and machine learning.
Discov Oncol
Zhao Q, Zhao Z, Du K.
PMID: 41307603 [PubMed - as supplied by publisher]


FigATree: a novel framework for histological subtyping and grading of lung adenocarcinoma.
Virchows Arch
Huang Q, Zhang J, He Q, Wang S, Zhang Q, Lin L, Yu X, Wang Y, He Y, Li H, Guan T, Chen X.
PMID: 41307585 [PubMed - as supplied by publisher]


Effect of angiotensin II receptor blockers on efficacy and safety of Camrelizumab plus chemotherapy in the first-line therapy for advanced non-small cell lung cancer (ARMOR I): a protocol for a prospective, real-world, multicenter, intervention clinical trial.
Front Immunol
Wang Z, Wang H, Hou R, Jiang H, Fan H, Zhang Y, Zhu Y, Cai Y, Mei J, Xu J.
PMID: 41306970 [PubMed - indexed for MEDLINE]


Immune checkpoint inhibitors continuation beyond progression as second-line treatment for extensive-stage small-cell lung cancer: a real-world, multicenter analysis.
Front Immunol
Zhang J, Zi R, Zhang HX, Lv Y, Zhao LJ, Wang Y.
PMID: 41306967 [PubMed - indexed for MEDLINE]


Efficacy and prognostic analysis of chemo-immunotherapy after TKI resistance in EGFR-mutant non-small cell lung cancer with TP53 or KRAS co-mutations.
Front Immunol
Nie Y, Song C, Wu K, Yu M, Hu J, Liu S, Hui F.
PMID: 41306958 [PubMed - indexed for MEDLINE]


Optimizing Diagnostic Strategies for Malignant Serous Cavity Effusion: The Role of Cytomorphological Examination Combined with High Fluorescent Cells and Total Protein.
Malawi Med J
Zhang N, Duan Y, Mughogho TS, Ndovi DM, Kaseka R, Hu J, Zheng J, Wang X.
PMID: 41306801 [PubMed - indexed for MEDLINE]


Post-translational modifications of protein and lung cancer.
Front Oncol
Zhao Y, Song X, Luo W, Xie F, Shen J, He J, Han Z, Huang J.
PMID: 41306527 [PubMed]


A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer.
Front Oncol
Zhu Z, Zan Y, Jiang M, Zhang R, Chen D, Dong G.
PMID: 41306526 [PubMed]


A Nomogram for Predicting Lung Metastasis in Papillary Thyroid Cancer Patients Aged Less Than 55 Years.
Front Endocrinol (Lausanne)
Yang H, Qian Q, Li Y, Pan W, Peng J, Zou Z, Zhu H, Shi F.
PMID: 41306438 [PubMed - indexed for MEDLINE]


Assessment of diagnostic efficacy: High fluorescent cells combined with CEA, NSE, and Cyfra21-1 in Malignant Pleural Effusion Identification.
Malawi Med J
Zhang N, Mughogho TS, Nothale A, Ndovi DM, Kaseka R, Wang Z, Hu J, Zheng J, Wang X.
PMID: 41306356 [PubMed - indexed for MEDLINE]


Applications and Complementarity of Organ-Chips and Animal Models in Lung Cancer Driver Gene Research.
Cell Biol Int
Wang LK, Wu TJ, Tsai FM.
PMID: 41306081 [PubMed - as supplied by publisher]


Retrospective comparative study of thoracoscopic lobectomy vs. segmentectomy: Enhancing recovery and lung function in early-stage non-small cell lung cancer.
Medicine (Baltimore)
Xu Z, Li C, Ni Y, Gu B, Zhou H, Luo Y, Chen S.
PMID: 41305814 [PubMed - indexed for MEDLINE]


Case report and literature review of pleural myeloid sarcoma.
Medicine (Baltimore)
Wang X, Liu J.
PMID: 41305736 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 154405    Seite 1 von 7721  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1